Trent J - Search Results

1

Intra- and intermolecular triplex DNA formation in the murine c-myb proto-oncogene promoter are inhibited by mithramycin.

Vigneswaran N, Thayaparan J, Knops J, Trent J, Potaman V, Miller DM, Zacharias W. Vigneswaran N, et al. Among authors: trent j. Biol Chem. 2001 Feb;382(2):329-42. doi: 10.1515/BC.2001.040. Biol Chem. 2001. PMID: 11308031

2

The integral divalent cation within the intermolecular purine*purine. pyrimidine structure: a variable determinant of the potential for and characteristics of the triple helical association.

Blume SW, Lebowitz J, Zacharias W, Guarcello V, Mayfield CA, Ebbinghaus SW, Bates P, Jones DE Jr, Trent J, Vigneswaran N, Miller DM. Blume SW, et al. Among authors: trent j. Nucleic Acids Res. 1999 Jan 15;27(2):695-702. doi: 10.1093/nar/27.2.695. Nucleic Acids Res. 1999. PMID: 9862999 Free PMC article.

3

Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate.

Koh JS, Trent J, Chen L, El-Naggar A, Hunt K, Pollock R, Zhang W. Koh JS, et al. Among authors: trent j. Histol Histopathol. 2004 Apr;19(2):565-74. doi: 10.14670/HH-19.565. Histol Histopathol. 2004. PMID: 15024716 Review.

4

Oncogene regulation of endonuclease activation in apoptosis.

McConkey DJ, Fernandez A, Trent J 2nd, Ananthaswamy HN. McConkey DJ, et al. Among authors: trent j 2nd. Cancer Lett. 1995 Jul 20;94(1):9-16. doi: 10.1016/0304-3835(95)03835-k. Cancer Lett. 1995. PMID: 7621450

5

Ras signaling in tumor necrosis factor-induced apoptosis.

Trent JC 2nd, McConkey DJ, Loughlin SM, Harbison MT, Fernandez A, Ananthaswamy HN. Trent JC 2nd, et al. EMBO J. 1996 Sep 2;15(17):4497-505. EMBO J. 1996. PMID: 8887541 Free PMC article.

6

Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates.

Woodman SE, Trent JC, Stemke-Hale K, Lazar AJ, Pricl S, Pavan GM, Fermeglia M, Gopal YN, Yang D, Podoloff DA, Ivan D, Kim KB, Papadopoulos N, Hwu P, Mills GB, Davies MA. Woodman SE, et al. Among authors: trent jc. Mol Cancer Ther. 2009 Aug;8(8):2079-85. doi: 10.1158/1535-7163.MCT-09-0459. Epub 2009 Aug 11. Mol Cancer Ther. 2009. PMID: 19671763 Free PMC article.

7

Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?

Scaife CL, Hunt KK, Patel SR, Benjamin RS, Burgess MA, Chen LL, Trent J, Raymond AK, Cormier JN, Pisters PW, Pollock RE, Feig BW. Scaife CL, et al. Among authors: trent j. Am J Surg. 2003 Dec;186(6):665-9. doi: 10.1016/j.amjsurg.2003.08.023. Am J Surg. 2003. PMID: 14672776

8

Tyrosine kinase inhibitors and the dawn of molecular cancer therapeutics.

Tibes R, Trent J, Kurzrock R. Tibes R, et al. Among authors: trent j. Annu Rev Pharmacol Toxicol. 2005;45:357-84. doi: 10.1146/annurev.pharmtox.45.120403.100124. Annu Rev Pharmacol Toxicol. 2005. PMID: 15822181 Review.

9

Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.

Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW. Andtbacka RH, et al. Among authors: trent j. Ann Surg Oncol. 2007 Jan;14(1):14-24. doi: 10.1245/s10434-006-9034-8. Ann Surg Oncol. 2007. PMID: 17072676

10

Molecular approaches to resolve diagnostic dilemmas: the case of gastrointestinal stromal tumor and leiomyosarcoma.

Trent JC, Lazar AJ, Zhang W. Trent JC, et al. Future Oncol. 2007 Dec;3(6):629-37. doi: 10.2217/14796694.3.6.629. Future Oncol. 2007. PMID: 18041915 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

966 results

Search Page